1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats (RFA-AI-27-014) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
This Notice of Funding Opportunity (NOFO) invites Small Business Innovation Research (SBIR) grant applications from small business concerns proposing research and development of medical devices and technologies to diagnose, mitigate, and treat acute and delayed effects of radiation or chemical exposures during and after a public health emergency.
This includes the development of radiation-focused models, biomarkers of damage, and devices to assess and predict injury.
Get alerted about grants like this
Save a search for “National Institute of Allergy and Infectious Diseases (NIAID)” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Small businesses are eligible. Other eligible applicants include various governmental and non-profit organizations, and institutions of higher education. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates See official notice Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is July 14, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Research Project Grant (Parent R01 Clinical Trial Not Allowed) is a flagship NIH grant administered by the National Institute of Allergy and Infectious Diseases that funds investigator-initiated biomedical and behavioral research projects not involving clinical trials. The R01 supports hypothesis-driven research across a wide range of health topics including infectious diseases, immune disorders, and allergy-related conditions. Eligible applicants include higher education institutions such as public and private universities. Award amounts range from $250,000 to $2,500,000 with a deadline of June 5, 2026.
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This program supports the establishment of Tuberculosis (TB) Research Advancement Centers (TRACs) to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB re…